Grow Therapy vs Moderna

Side-by-side comparison of AI visibility scores, market position, and capabilities

Moderna leads in AI visibility (90 vs 72)
Grow Therapy logo

Grow Therapy

LeaderDigital Health

Mental Health Marketplace

Raised $150M Series D (Mar 2026) led by TCV and Goldman Sachs Alternatives. $1B+ annualized revenue. 7M visits in 2025. 26K providers, 220M covered lives.

AI VisibilityBeta
Overall Score
B72
Category Rank
#103 of 596
AI Consensus
86%
Trend
stable
Per Platform
ChatGPT
70
Perplexity
70
Gemini
72

About

Grow Therapy is the largest insurance-covered mental health provider marketplace in the US, connecting 26,000 therapists and psychiatrists with patients across 220 million covered lives. The company raised $150 million in Series D financing in March 2026 led by TCV and Goldman Sachs Alternatives after crossing $1 billion in annualized revenue — rare proof of genuine unit economics in behavioral health, which has historically struggled to achieve profitability at scale.

Full profile
Moderna logo

Moderna

LeaderHealthcare Tech

Enterprise

mRNA pioneer with $3.2B FY2024 revenue (down from $18.4B 2022 COVID peak); mRESVIA RSV vaccine approved 2024; personalized cancer vaccine with Merck shows 44% recurrence reduction in melanoma.

AI VisibilityBeta
Overall Score
A90
Category Rank
#2 of 596
AI Consensus
83%
Trend
stable
Per Platform
ChatGPT
92
Perplexity
93
Gemini
89

About

Moderna is a clinical-stage biotechnology company that pioneered the development of messenger RNA (mRNA) therapeutics and vaccines, founded in 2010 by Noubar Afeyan, Robert Langer, Kenneth Chien, Stéphane Bancel, and others in Cambridge, Massachusetts, where it is headquartered and trades on Nasdaq (MRNA). The company achieved extraordinary commercial success with Spikevax, its COVID-19 mRNA vaccine developed in partnership with the U.S. government in 2020—generating $18.4 billion in COVID vaccine revenues in 2022 at peak—before experiencing a severe revenue decline as global COVID booster demand normalized. For FY2024, Moderna generated approximately $3.2 billion in revenues, with Spikevax and the reformulated XBB.1.5-targeting COVID vaccine contributing the majority, while the company's significant R&D investment pipeline consumed most operating cash flows.

Full profile

AI Visibility Head-to-Head

72
Overall Score
90
#103
Category Rank
#2
86
AI Consensus
83
stable
Trend
stable
70
ChatGPT
92
70
Perplexity
93
72
Gemini
89
68
Claude
96
74
Grok
95

Key Details

Category
Mental Health Marketplace
Enterprise
Tier
Leader
Leader
Entity Type
brand
company

Capabilities & Ecosystem

Capabilities

Only Grow Therapy
Mental Health Marketplace

Integrations

Only Grow Therapy
Only Moderna
Moderna is classified as company.

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.